The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis

Nefrología - Tập 43 - Trang 731-741 - 2023
Xuanwei Li1, Wenlai Li1, Yue Li2, Chuanjiang Dong3, Ping Zhu1
1Division of Nephrology, The First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei, China
2Division of Endocrinology, The Renhe Hospital of Three Gorges University, Yichang, Hubei, China
3Division of Urinary Surgery, The First College of Clinical Medical Science, Three Gorges University , Yichang, Hubei, China

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Nefrología

Tập 43

731-741

Thông tin tác giả